1. Home
  2. EXTR vs MIRM Comparison

EXTR vs MIRM Comparison

Compare EXTR & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXTR
  • MIRM
  • Stock Information
  • Founded
  • EXTR 1996
  • MIRM 2018
  • Country
  • EXTR United States
  • MIRM United States
  • Employees
  • EXTR N/A
  • MIRM N/A
  • Industry
  • EXTR Telecommunications Equipment
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXTR Telecommunications
  • MIRM Health Care
  • Exchange
  • EXTR Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • EXTR 2.6B
  • MIRM 3.3B
  • IPO Year
  • EXTR 1999
  • MIRM 2019
  • Fundamental
  • Price
  • EXTR $22.30
  • MIRM $74.19
  • Analyst Decision
  • EXTR Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • EXTR 6
  • MIRM 10
  • Target Price
  • EXTR $21.42
  • MIRM $74.20
  • AVG Volume (30 Days)
  • EXTR 1.3M
  • MIRM 712.4K
  • Earning Date
  • EXTR 10-29-2025
  • MIRM 11-11-2025
  • Dividend Yield
  • EXTR N/A
  • MIRM N/A
  • EPS Growth
  • EXTR N/A
  • MIRM N/A
  • EPS
  • EXTR N/A
  • MIRM N/A
  • Revenue
  • EXTR $1,140,067,000.00
  • MIRM $429,161,000.00
  • Revenue This Year
  • EXTR $10.26
  • MIRM $53.08
  • Revenue Next Year
  • EXTR $7.48
  • MIRM $20.45
  • P/E Ratio
  • EXTR N/A
  • MIRM N/A
  • Revenue Growth
  • EXTR 2.05
  • MIRM 62.33
  • 52 Week Low
  • EXTR $10.10
  • MIRM $36.86
  • 52 Week High
  • EXTR $22.89
  • MIRM $78.10
  • Technical
  • Relative Strength Index (RSI)
  • EXTR 63.30
  • MIRM 62.63
  • Support Level
  • EXTR $22.10
  • MIRM $73.70
  • Resistance Level
  • EXTR $22.89
  • MIRM $76.87
  • Average True Range (ATR)
  • EXTR 0.62
  • MIRM 2.49
  • MACD
  • EXTR -0.01
  • MIRM -0.70
  • Stochastic Oscillator
  • EXTR 74.35
  • MIRM 42.28

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: